Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) Stock Information | RedChip

Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)


$4.2900
+0.1000 ( +2.88% ) 218.0K

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Market Data


Open


$4.2900

Previous close


$4.1900

Volume


218.0K

Market cap


$248.52M

Day range


$3.9500 - $4.2950

52 week range


$1.5199 - $5.5400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
def Proxies and info statements 16 May 30, 2024
ars Annual reports 1 May 30, 2024
10-q Quarterly Reports 63 May 15, 2024
8-k 8K-related 13 May 13, 2024
4 Insider transactions 1 May 13, 2024
8-k 8K-related 18 May 07, 2024

Latest News